saxagliptin - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
QTERN 5/10 saxagliptin (as hydrochloride) / dapagliflozin (as propanediol monohydrate) 5 mg / 10 mg film-coated tablet blister pack AUST R: 255632Active ingredients:
dapagliflozin propanediol monohydrate
saxagliptin
Dosage form:
Tablet
Sponsor:
AstraZeneca Pty Ltd
Phone:
1800805342
|
Deletion from market:
01 Jul 2026
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
The sponsor will continue to supply until the market deletion date.
|